Celine M Laffont

Celine M Laffont is a prominent inventor based in Richmond, VA (US). She has made significant contributions to the field of medicine, particularly in the development of dosing regimens for buprenorphine. With a total of three patents to her name, Laffont's work is focused on improving treatment options for patients dealing with pain and opioid use disorders.

Latest Patents

Laffont's latest patents include innovative approaches to buprenorphine dosing regimens. The disclosures provide a dosage regimen using sustained-release buprenorphine formulations to achieve therapeutic levels of the drug in patients. This advancement is crucial for effectively managing pain and addressing opioid use disorders.

Career Highlights

Celine M Laffont is currently associated with Indivior UK Limited, where she continues to work on her research and development projects. Her expertise in pharmacology and drug formulation has positioned her as a key player in the pharmaceutical industry.

Collaborations

Laffont collaborates with notable colleagues such as Azmi Nasser and Christian A Heidbreder. These partnerships enhance her research efforts and contribute to the advancement of innovative treatment solutions.

Conclusion

Celine M Laffont's contributions to buprenorphine dosing regimens highlight her dedication to improving patient care in the realm of pain management and opioid use disorders. Her work continues to influence the pharmaceutical landscape positively.

This text is generated by artificial intelligence and may not be accurate.